Skip to Main content Skip to Navigation
New interface

Amélioration de l'efficacité en thérapie photodynamique par couplage d'un photosensibilisateur à des molécules actives

Abstract : To improve tumor cells selectivity and/or photodynamic therapy (PDT) anti-tumor efficiency, active molecules (peptides, pseudopeptides, alkylating agents) have been conjugated to the photo-activable molecule. In a first part, vascular effect of PDT has been promoted by targeting the tumor vasculature with angiogenic phenotype. A chlorine-type photosensitizer have been coupled to a neuropilin-1 (NRP-1)-targeting peptide and has shown its in vitro and in vivo anti-tumor efficiency for PDT. However, the peptidic sequence has been degraded in vivo. Clivage site-modified pseudopeptides have been synthesized and tested in vitro, conjugated to TPC or not. Chlorine cellular uptake has been improved after coupling with pseudopeptides. A technique of RNA interference-mediated silencing of NRP-1 in MDA-MB-231, over-expressing NRP-1, has highlighted the receptor-dependent uptake of the conjugates and their cellular selectivity. Pseudopeptides and conjugates have shown their NRP-1 affinity and their in vivo stability. Ruthenium (Ru) is considered as an interest therapeutic molecule in oncology. In a second part, we have studied the in vivo interest of coupling an alkylating agent with porphyrine and chlorine-type photosensitizers. The in vivo efficiency studies on nude mice xenografted ectopically with KB cells have been carried using experimental design approach. Two in vitro efficient conjugates [Ru(_6-p-PriC6H4Me)(5-(3-pyridyl)-10,15,20-triphenylporphyrin)Cl2, or Rut1, and Ru4(_6-p-PriC6H4Me)4(5,10,15,20-tetra(3-pyridyl)porphyrin)Cl8, or Rut4] have been compared in vivo. Rut4 conjugate has appeared to be more efficient than Rut1. Biodistribution studies using fiber spectrofluorimeter and classic pharmacokinetic studies have shown an optimal drug-light interval of 24h. However, after PDT parameters optimization, the Ru coupling with a photo-activable molecule (porphyrin or chlorine) hasn?t shown any significant in vivo anti-tumor efficiency
Document type :
Complete list of metadata
Contributor : Thèses UL Connect in order to contact the contributor
Submitted on : Thursday, March 29, 2018 - 12:21:07 PM
Last modification on : Saturday, October 16, 2021 - 11:14:14 AM
Long-term archiving on: : Friday, September 14, 2018 - 10:09:26 AM


Files produced by the author(s)


  • HAL Id : tel-01749609, version 1


Marlène Pernot. Amélioration de l'efficacité en thérapie photodynamique par couplage d'un photosensibilisateur à des molécules actives. Médecine humaine et pathologie. Université de Lorraine, 2012. Français. ⟨NNT : 2012LORR0195⟩. ⟨tel-01749609⟩



Record views


Files downloads